EndoClot Plus
Pre-clinicalEndoClot Plus, Inc. (EPI) is a privately held medical device company in Santa Clara, California. In collaboration with endoscopists and biomaterial scientists, EPI developed EndoClot® Polysaccharide Hemostatic System (EndoClot® PHS), a breakthrough technology to control bleeding in the gastrointestinal tract by spraying a proprietary powder directly to the wound during endoscopy.
About
EndoClot Plus, Inc. (EPI) is a privately held medical device company in Santa Clara, California. In collaboration with endoscopists and biomaterial scientists, EPI developed EndoClot® Polysaccharide Hemostatic System (EndoClot® PHS), a breakthrough technology to control bleeding in the gastrointestinal tract by spraying a proprietary powder directly to the wound during endoscopy.
Funding History
1Total raised: $5M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile